Sigma-1 Receptor Activation Prevents Intracellular Calcium Dysregulation in Cortical Neurons during in Vitro Ischemia

• Published in: The Journal of pharmacology and experimental therapeutics 2006-12, Vol.319 (3), p.1355-1365
• Main Authors: Katnik, Christopher, Guerrero, Waldo R., Pennypacker, Keith R., Herrera, Yelenis, Cuevas, Javier
• Format: Article
• Language: English
• Subjects: Analgesics, Opioid - pharmacology; Animals; Brain Ischemia - metabolism; Calcium - metabolism; Calcium Signaling - drug effects; Calcium Signaling - physiology; Cerebral Cortex - cytology; Cerebral Cortex - drug effects; Cerebral Cortex - metabolism; Cyclopentanes - pharmacology; Cytophotometry; Enzyme Inhibitors - pharmacology; Ethylenediamines - pharmacology; Female; Guanidines - pharmacology; Morpholines - pharmacology; Neurons - metabolism; Pentazocine - pharmacology; Phencyclidine - analogs & derivatives; Phencyclidine - pharmacology; Pregnancy; Rats; Receptors, N-Methyl-D-Aspartate - drug effects; Receptors, sigma - agonists; Receptors, sigma - antagonists & inhibitors; Receptors, sigma - drug effects; Sigma-1 Receptor; Sodium Azide - pharmacology; Sodium Channel Agonists; Tetrodotoxin - pharmacology
• ISSN: 0022-3565; 1521-0103
• DOI: 10.1124/jpet.106.107557

Sigma receptors are putative targets for neuroprotection following ischemia; however, little is known on their mechanism of action. One of the key components in the demise of neurons following ischemic injury is the disruption of intracellular calcium homeostasis. Fluorometric calcium imaging was used to examine the effects of sigma receptor activation on changes in intracellular calcium concentrations ([Ca2+]i) evoked by in vitro ischemia in cultured cortical neurons from embryonic rats. The sigma receptor agonist, 1,3-di-o-tolyl-guanidine (DTG), was shown to depress [Ca2+]i elevations observed in response to ischemia induced by sodium azide and glucose deprivation. Two sigma receptor antagonists, metaphit [1-(1-(3-isothiocyanatophenyl)-cyclohexyl)-piperidine] and BD-1047 (N-[2–3,4-dichlorophenyl)-ethyl]-N-methyl-2-(dimethylamino)ethylamine), were shown to blunt the ability of DTG to inhibit ischemia-evoked increases in [Ca2+]i, revealing that the effects are mediated by activation of sigma receptors and not via the actions of DTG on nonspecific targets such as N-methyl-d-aspartate receptors. DTG inhibition of ischemia-induced increases in [Ca2+]i was mimicked by the σ-1 receptor-selective agonists, carbetapentane, (+)-pentazocine and PRE-084 [2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochloride], but not by the sigma-2-selective agonist, ibogaine, showing that activation of sigma-1 receptors is responsible for the effects. In contrast, DTG, carbetapentane, and ibogaine blocked spontaneous, synchronous calcium transients observed in our preparation at concentrations consistent with sigma receptor-mediated effects, indicating that both sigma-1 and sigma-2 receptors regulate events that affect [Ca2+]i in cortical neurons. Our studies show that activation of sigma receptors can ameliorate [Ca2+]i dysregulation associated with ischemia in cortical neurons and, thus, identify one of the mechanisms by which these receptors may exert their neuroprotective properties.